Providence Blood Cancers and Blood Disorders Program
At Providence, whether you’re diagnosed with a blood disorder or blood cancer, our team of hematology specialists will guide your treatment with compassion and expertise.
Providence Blood Cancers and Blood Disorders Program
At Providence, whether you’re diagnosed with a blood disorder or blood cancer, our team of hematology specialists will guide your treatment with compassion and expertise.
Our Approach
As one of the few highly specialized blood cancer treatment programs in the region, the team of blood disorder experts at Providence Cancer Institute of Oregon – a diverse group of experts known as hematologists – provide care to people diagnosed with blood disorders and blood cancers. Our treatment plans also include highly personalized, promising new therapies like chimeric antigen receptor (CAR) T-cell therapy.
Through the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy, we give patients the opportunity to participate in innovative clinical trials to treat leukemia, lymphoma, myelodysplastic syndromes and myeloma.
We have many teams that support patients during their treatment. Our collaborative, team-based approach to cancer care includes:
- Advanced practice providers
- Fellowship-trained hematologists
- Fellowship-trained oncologists
- Integrative medicine clinicians
- Oncology nurses
- Pathologists
- Radiation oncologists
- Registered dietitians
- Social workers
In addition to medical care, they also offer emotional and practical support so patients can stay focused on their treatment and overall well-being.
Meet the Team
At Providence, you'll have access to a vast network of dedicated and compassionate providers who offer personalized care by focusing on treatment, prevention and health education.
Specialists at Providence Cancer Institute of Oregon treat adult blood cancers, including:
- Leukemia
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Adult T-cell leukemia/lymphoma (ATLL)
- Chronic lymphocytic leukemia (CLL)
- Chronic myeloid leukemia (CML)
- Lymphoma
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Multiple myeloma
- Amyloidosis
- Monoclonal gammopathy of undetermined significance (MGUS)
- Myeloma
- Plasmacytoma
- Smoldering myeloma
Blood cancer treatment options may include:
- Autologous stem cell transplant: In an autologous stem cell transplant, your stem cells are first collected and preserved. Then, you receive high-dose chemotherapy or radiation to destroy diseased cells. Afterward, your own stem cells are reinfused to help your body recover and restore healthy blood production. As one of two accredited stem cell transplant locations in Oregon, our transplant team has extensive experience supporting patients throughout this treatment.
- Cellular therapies: Available through our FDA-approved treatments and clinical trials, cellular therapies use your own cells to fight disease and support recovery. One type of adoptive T-cell therapy, called CAR T-cell therapy, can be used to treat certain types of leukemia, lymphoma and multiple myeloma.
- Chemotherapy: This can include immunotherapy, targeted therapies or other cytotoxic chemicals to kill cancer cells.
- Clinical trials: Available through the Earle A. Chiles Research Institute, your care team will identify if any trials are appropriate for you. You can also ask about clinical trial opportunities.
Our hematologists also provide exceptional care for non-cancer blood disorders, bringing their expertise, advanced diagnostic capabilities and a commitment to education for both clinicians and patients. They coordinate closely with several specialties, including OB-GYN, cardiology and surgery, to develop personalized treatment plans and ensure comprehensive care.
Together, we treat the following conditions:
- Autoimmune disorder affecting blood cells
- Bleeding disorders, such as von Willebrand disease, hemophilia and platelet disorders
- Bone marrow failure syndromes
- Castleman disease
- Hemoglobinopathies, including thalassemia and sickle cell disease
- Hemophagocytic lymphohistiocytosis (HLH)
- Hypercoagulable states and venous thrombosis
- Iron disorders, including iron deficiency and iron overload
- Low blood cell counts, including white blood cells, red blood cells and platelets
- Microangiopathic hemolytic anemias
- Porphyria
Why Choose Us for Your Cancer Care?
Accreditation
Our program has been accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) since 2000. This accreditation allows us to perform transplant protocols through the Bone Marrow Transplant Clinical Trials Network (BMT CTN) and the Southwest Oncology Group (SWOG).
CAR T-Cell Therapy: Using Your Immune Cells to Fight Blood Cancers
Providence is home to the first research laboratory in Oregon for adoptive cellular therapy, a type of cancer immunotherapy. We offer advanced cell therapies through both FDA approved treatments and clinical trials, including chimeric antigen receptor (CAR) T-cell therapy.
Part of Providence Cancer Institute of Oregon
Providence Cancer Institute is a leading provider of cancer care in Oregon, and part of the largest community-based cancer-care network in the United States. Regardless of where you go for care, you have an entire team of cancer experts working together to provide a personalized, whole-person approach to your care. At Providence we see more than a cancer diagnosis, we see the life in you and are committed to helping you live well again.
Find Clinical Trials
Are you looking for a clinical trial for yourself or for a patient? We’d love to help you find one!